Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature

被引:104
作者
Oliver, KR
Wainwright, A
Edvinsson, L
Pickard, JD
Hill, RG
机构
[1] Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
[2] Univ Lund Hosp, Dept Internal Med, S-22185 Lund, Sweden
[3] Addenbrookes Hosp, Dept Neurosurg, Cambridge, England
基金
英国医学研究理事会;
关键词
immunohistochemistry; trigeminovascular system; peptide receptors;
D O I
10.1097/00004647-200205000-00014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcitonin gene-related peptide and adrenomedullin belong to a structurally related neuropeptide family and are potent vasodilators expressed in the trigeminovascular system. The molecular identity of receptors for these proteins has only recently been elucidated. Central to functional binding of these neuropeptides is the G-protein-coupled receptor, the calcitonin receptor-like receptor (CRLR), Whose cell surface expression and pharmacology is determined by coexpression of a receptor activity-modifying protein (RAMP). CRLR combined with RAMP1 binds calcitonin gene-related peptide With high affinity. whereas CRLR coexpression with RAMP2 or -3 confers, high-affinity binding of adrenomedullin. The authors investigated the expression of these receptor components in human cerebral vasculature to further characterize neuropeptide receptor content and the potential functions of these receptors. Localization has been carried out using specific antisera raised against immunogenic peptide sequences that were subsequently applied using modern immunohistochemical techniques and confocal microscopy. The results are the first to show the presence of these receptor component proteins in human middle meningeal, middle cerebral. pial, and superficial temporal vessels, and confirm that both calcitonin gene-related peptide and adrenomedullin receptors may arise from the coassembly of RAMPs with CRLR in these vessel type,,. These novel data advance the understanding of the molecular function of the trigeminovascular system, its potential role in vascular headache disorders such as migraine. and may lead to possible Ways in which future synthetic ligands may be applied to manage these disorders.
引用
收藏
页码:620 / 629
页数:10
相关论文
共 62 条
[1]   A cDNA encoding the calcitonin gene-related peptide type 1 receptor [J].
Aiyar, N ;
Rand, K ;
Elshourbagy, NA ;
Zeng, ZZ ;
Adamou, JE ;
Bergsma, DJ ;
Li, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11325-11329
[2]   Plasma levels of calcitonin gene-related peptide in chronic tension-type headache [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Schifter, S ;
Jansen-Olesen, I ;
Olesen, J .
NEUROLOGY, 2000, 55 (09) :1335-1340
[3]   Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks [J].
Ashina, M ;
Bendtsen, L ;
Jensen, R ;
Schifter, S ;
Olesen, J .
PAIN, 2000, 86 (1-2) :133-138
[4]   EFFECTS OF ADRENOMEDULLIN, CALCITONIN-GENE-RELATED PEPTIDE, AND AMYLIN ON CEREBRAL-CIRCULATION IN DOGS [J].
BASKAYA, MK ;
SUZUKI, Y ;
ANZAI, M ;
SEKI, Y ;
SAITO, K ;
TAKAYASU, M ;
SHIBUYA, M ;
SUGITA, K .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (05) :827-834
[5]   A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1 [J].
Bühlmann, N ;
Leuthäuser, K ;
Muff, R ;
Fischer, JA ;
Born, W .
ENDOCRINOLOGY, 1999, 140 (06) :2883-2890
[6]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[7]  
DENNIS T, 1990, J PHARMACOL EXP THER, V254, P123
[8]   Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist [J].
Doods, H ;
Hallermayer, G ;
Wu, DM ;
Entzeroth, M ;
Rudolf, K ;
Engel, W ;
Eberlein, W .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 129 (03) :420-423
[9]  
Durham PL, 1999, J NEUROSCI, V19, P3423
[10]   CALCITONIN GENE-RELATED PEPTIDE AND CEREBRAL BLOOD-VESSELS - DISTRIBUTION AND VASOMOTOR EFFECTS [J].
EDVINSSON, L ;
EKMAN, R ;
JANSEN, I ;
MCCULLOCH, J ;
UDDMAN, R .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1987, 7 (06) :720-728